Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

BACKGROUND: Digoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by the presence of heart failure (HF). METHODS...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Heart Assoc
Asıl Yazarlar: Eisen, Alon, Ruff, Christian T., Braunwald, Eugene, Hamershock, Rose A., Lewis, Basil S., Hassager, Christian, Chao, Tze‐Fan, Le Heuzey, Jean Yves, Mercuri, Michele, Rutman, Howard, Antman, Elliott M., Giugliano, Robert P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586309/
https://ncbi.nlm.nih.gov/pubmed/28666993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006035
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller